Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, has entered into a ...

BioMarin has entered into a definitive agreement to acquire Inozyme Pharma Inc. for a total consideration of approximately ...

The new board will work with Abzena's scientific and commercial leadership to provide strategic guidance and insights.

Manufacturing company groninger is investing over $14 million in new headquarters at its U.S. location in Charlotte, N.C.

Platinum Press Inc. (PPI) has commenced runs utilizing a digital printing system whose inks are free of volatile organic ...

AbbVie and ADARx Pharmaceuticals have signed a collaboration and license option agreement to develop small interfering RNA ...

This will support the development of mRNA-based vaccines and improve access in low- and middle-income countries.

AGC Biologics has partnered with Quell Therapeutics to support the development of multiple Treg cell therapy drug candidates.

Lars Fruergaard Jørgensen will step down from his role as CEO of Novo Nordisk. In the meantime, a search for Jørgensen’s successor is ongoing. Novo Nordisk says the leadership transition is “made in ...

FAMAR Group, a CDMO, has signed an agreement to acquire a sterile production site in Homburg, Germany, from MiP Pharma.

Septerna, Novo Nordisk partner to discover, develop and commercialize oral small molecule medicines for cardiometabolic ...

The company also appointed Pete Buzy, former President and CEO of Catalent Cell & Gene Therapy, to its Board of Directors.